InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.37%
)
Bitcoin
66,011.32
(
-1.12%
)

Replies to post #233010 on Amarin Corp Plc (AMRN)

Replies to #233010 on Amarin Corp Plc (AMRN)

rosemountbomber

12/13/19 7:57 AM

#233011 RE: Retiredceo #233010

That should be grounds for losing a license. Unless they cleared it with the doc first.

Albino2

12/13/19 8:32 AM

#233020 RE: Retiredceo #233010

It was my understanding that because the label is for the same treatment they can substitute. Once the label changes then it should not be allowed to be substituted when written for cardiovascular treatment.